Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk.

Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):698-708.

2.

Plasma phytoestrogens and subsequent breast cancer risk.

Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH.

J Clin Oncol. 2007 Feb 20;25(6):648-55. Epub 2007 Jan 2.

PMID:
17200150
3.

Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.

Low YL, Taylor JI, Grace PB, Dowsett M, Scollen S, Dunning AM, Mulligan AA, Welch AA, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):213-20.

4.

Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in men.

Low YL, Taylor JI, Grace PB, Dowsett M, Folkerd E, Doody D, Dunning AM, Scollen S, Mulligan AA, Welch AA, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA.

J Nutr. 2005 Nov;135(11):2680-6.

5.

Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.

Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S; European Prospective into Cancer-Norfolk cohort.

Breast Cancer Res. 2008;10(2):R32. doi: 10.1186/bcr1995. Epub 2008 Apr 17.

6.

Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database.

Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT.

Am J Clin Nutr. 2010 Feb;91(2):440-8. doi: 10.3945/ajcn.2009.28282. Epub 2009 Dec 9.

7.

Urinary and serum concentrations of seven phytoestrogens in a human reference population subset.

Valentín-Blasini L, Blount BC, Caudill SP, Needham LL.

J Expo Anal Environ Epidemiol. 2003 Jul;13(4):276-82.

8.

Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study.

Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2891-4. doi: 10.1158/1055-9965.EPI-08-0335.

9.

Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk.

Low YL, Taylor JI, Grace PB, Mulligan AA, Welch AA, Scollen S, Dunning AM, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA.

Nutr Cancer. 2006;56(1):31-9.

PMID:
17176215
10.

Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.

Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S.

J Epidemiol. 2000 Mar;10(2):127-35.

11.

Urinary phytoestrogens and postmenopausal breast cancer risk.

den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8.

12.

Profiles of phytoestrogens in human urine from several Asian countries.

Kunisue T, Tanabe S, Isobe T, Aldous KM, Kannan K.

J Agric Food Chem. 2010 Sep 8;58(17):9838-46. doi: 10.1021/jf102253j.

PMID:
20707345
13.

Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.

Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA.

J Nutr. 2002 Oct;132(10):3168-71.

14.

Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay.

Uehar M, Arai Y, Watanabe S, Adlercreutz H.

Biofactors. 2000;12(1-4):217-25.

PMID:
11216489
15.

Case-control study of phyto-oestrogens and breast cancer.

Ingram D, Sanders K, Kolybaba M, Lopez D.

Lancet. 1997 Oct 4;350(9083):990-4.

PMID:
9329514
16.

Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.

Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL, Lampe JW.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1156-62.

17.

Urinary isoflavone and lignan phytoestrogen levels and risk of uterine fibroid in Jamaican women.

Simon GA, Fletcher HM, Golden K, McFarlane-Anderson ND.

Maturitas. 2015 Oct;82(2):170-5. doi: 10.1016/j.maturitas.2015.06.041. Epub 2015 Jul 17.

PMID:
26223581
18.

Urinary phytoestrogen concentrations in the U.S. population (1999-2000).

Valentín-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB.

J Expo Anal Environ Epidemiol. 2005 Nov;15(6):509-23.

PMID:
15928707
19.

Quantification of isoflavones and lignans in urine using gas chromatography/mass spectrometry.

Grace PB, Taylor JI, Botting NP, Fryatt T, Oldfield MF, Bingham SA.

Anal Biochem. 2003 Apr 1;315(1):114-21.

PMID:
12672419
20.

Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake.

Lampe JW, Gustafson DR, Hutchins AM, Martini MC, Li S, Wähälä K, Grandits GA, Potter JD, Slavin JL.

Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):699-707.

Supplemental Content

Support Center